Ladenburg Thalmann Initiates Auspex Pharma At Buy

Analysts at Ladenburg Thalmann initiated coverage on shares of Auspex Pharma

with a Buy rating. The target price for Auspex Pharma is set to $37. Auspex Pharma's shares fell 1.87% to close at $21.56 yesterday.